Cargando…
RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer
SIMPLE SUMMARY: Despite the increasing number of treatments for advanced prostate cancer, the evaluation of the added value of each line of treatment on survival outcome is challenging. Therefore, biomarkers to discriminate short-term survivors from long-term survivors shortly after start of treatme...
Autores principales: | Boerrigter, Emmy, Benoist, Guillemette E., van Oort, Inge M., Verhaegh, Gerald W., de Haan, Anton F. J., van Hooij, Onno, Groen, Levi, Smit, Frank, Oving, Irma M., de Mol, Pieter, Smilde, Tineke J., Somford, Diederik M., Hamberg, Paul, Dezentjé, Vincent O., Mehra, Niven, van Erp, Nielka P., Schalken, Jack A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699291/ https://www.ncbi.nlm.nih.gov/pubmed/34944897 http://dx.doi.org/10.3390/cancers13246279 |
Ejemplares similares
-
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment
por: Boerrigter, Emmy, et al.
Publicado: (2021) -
Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor—Darolutamide
por: Podgoršek, Eva, et al.
Publicado: (2023) -
The effect of chemotherapy on the exposure–response relation of abiraterone in metastatic castration‐resistant prostate cancer
por: Boerrigter, Emmy, et al.
Publicado: (2021) -
The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients
por: Benoist, Guillemette E., et al.
Publicado: (2020) -
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics
por: Lubberman, Floor J. E., et al.
Publicado: (2019)